University of Louisville, Department of Psychiatry and Behavioral Sciences
Welcome,         Profile    Billing    Logout  
 3 Trials 
11 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ali, Ziad
NCT03507777: ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Completed
N/A
2487
Europe, Canada, Japan, US, RoW
Coronary PCI guided by OCT, Optical Coherence Tomography, Coronary PCI guided by Angiography
Abbott Medical Devices, Abbott
Coronary Artery Disease, Coronary Stenosis, Atherosclerosis, STEMI, STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
02/23
02/23
PROGRESS CTO, NCT02061436: Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

Recruiting
N/A
2000
Europe, Canada, US, RoW
Minneapolis Heart Institute Foundation
Coronary Artery Disease
01/24
01/24
NCT06018194: ELUCIDATE FFRct Study

Recruiting
N/A
350
US
ElucidVivo
Elucid Bioimaging Inc., Lundquist Institute at Harbor-UCLA Medical Center
Coronary Artery Disease
07/24
07/24
OPTOCAB, NCT05129228: Optical Coherence Tomography of the Saphenous Vein Graft

Recruiting
N/A
760
US
OCT-guided saphenous vein CABG, ILUMIEN OPTIS NEXT OCT Imaging System, ILUMIEN OPTIS OCT Imaging System, OPTIS Integrated OCT Imaging System, OPTIS Mobile OCT Imaging System, Dragonfly Duo Catheter, Dragonfly OPTIS Catheter, Dragonfly OpStar Imaging Catheter, Dual Channel AureFlo Systems, Coronary Flowprobes
St. Francis Hospital, New York
Coronary Bypass Graft Stenosis
04/24
04/26
NCT03786614: Antidepressant Discontinuation in Treatment Resistant Depression

Recruiting
N/A
30
US
Discontinuation of serotonergic antidepressants, Continuation of serotonergic medications
University of Louisville
Treatment Resistant Depression
12/24
12/24
SPIRIT XLV PAS, NCT05423379: XIENCE Skypoint Large Vessel Post Approval Study

Active, not recruiting
N/A
102
Europe, US
XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS)
Abbott Medical Devices
Coronary Artery Disease
08/25
08/27
El-Mallakh, Rifaat S
NCT05169710 / 2021-002126-24: A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Terminated
3
83
Europe, Canada, Japan, US
SEP-4199 CR 200 mg, SEP-4199 CR 400 mg, Placebo
Sumitomo Pharma America, Inc., Sunovion Pharmaceuticals Inc.
Depressive Episodes, Bipolar I Depression
10/23
10/23
NCT03786614: Antidepressant Discontinuation in Treatment Resistant Depression

Recruiting
N/A
30
US
Discontinuation of serotonergic antidepressants, Continuation of serotonergic medications
University of Louisville
Treatment Resistant Depression
12/24
12/24
El-Mallakh, Rif S
NCT03786614: Antidepressant Discontinuation in Treatment Resistant Depression

Recruiting
N/A
30
US
Discontinuation of serotonergic antidepressants, Continuation of serotonergic medications
University of Louisville
Treatment Resistant Depression
12/24
12/24
Nuss, Sharon
NCT03786614: Antidepressant Discontinuation in Treatment Resistant Depression

Recruiting
N/A
30
US
Discontinuation of serotonergic antidepressants, Continuation of serotonergic medications
University of Louisville
Treatment Resistant Depression
12/24
12/24
Miozza, Lucas
NCT03786614: Antidepressant Discontinuation in Treatment Resistant Depression

Recruiting
N/A
30
US
Discontinuation of serotonergic antidepressants, Continuation of serotonergic medications
University of Louisville
Treatment Resistant Depression
12/24
12/24

Download Options